936 results on '"Song, Ho June"'
Search Results
102. Long-term Outcomes and Factors Affecting the Survival of Patients with Mucosal Esophageal Squamous Cell Carcinoma
103. Initial Stage Affects Survival Even After Complete Pathologic Remission is Achieved in Locally Advanced Esophageal Cancer: Analysis of 70 Patients With Pathologic Major Response After Preoperative Chemoradiotherapy
104. Endoscopic scoring system for gastric atrophy and intestinal metaplasia: correlation with OLGA and OLGIM staging: a single-center prospective pilot study in Korea.
105. Clinical outcomes of endoscopic and surgical management for postoperative upper gastrointestinal leakage
106. Clinical outcomes of argon plasma coagulation for the treatment of gastric neoplasm
107. Searching for E-cadherin gene mutations in early onset diffuse gastric cancer and hereditary diffuse gastric cancer in Korean patients
108. Outcomes of balloon dilation for the treatment of strictures after endoscopic submucosal dissection compared with peptic strictures
109. Is transnasal endoscope-assisted endoscopic submucosal dissection for gastric neoplasm useful in training beginners? A prospective randomized trial
110. Proper preparation to reduce endoscopic reexamination due to food residue after distal gastrectomy for gastric cancer
111. Clinicopathologic Characteristics and Mucin Expression in Brunner’s Gland Proliferating Lesions
112. Impact of Comorbidities, Sarcopenia, and Nutritional Status on the Long-Term Outcomes after Endoscopic Submucosal Dissection for Early Gastric Cancer in Elderly Patients Aged ≥ 80 Years
113. Prospective evaluation of the efficacy of peroral endoscopic myotomy in patients with achalasia
114. Is Ex Vivo Training before In Vivo Training Effective in Learning Gastric Endoscopic Submucosal Dissection?
115. ID: 3525627 PREDICTIVE VALUE OF INTRAOPERATIVE ESOPHAGEAL FUNCTIONAL LUMINAL IMAGING PROBE(FLIP) PANOMETRY IN PATIENTS WITH ACHALASIA UNDERGOING PERORAL ENDOSCOPIC MYOTOMY: A SINGLE-CENTER EXPERIENCE
116. Additional file 1 of Clinical outcomes of endoscopic removal of foreign bodies from the upper gastrointestinal tract
117. Surveillance Strategy of Atrophic Gastritis and Intestinal Metaplasia in a Country with a High Prevalence of Gastric Cancer
118. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data
119. Endoscopic treatment of malignant gastric or duodenal obstruction using self-expandable metal stent placement: P-711
120. Clinical outcomes of endoscopic resection of gastric gastrointestinal stromal tumor: P-710
121. Clinical outcomes of endoscopic bleeding control in patients with gastric cancer: P-337
122. Efficacy and safety of endoscopic resection for gastric neoplasm in patients with liver cirrhosis: a case-control study: P-192
123. Endoscopic and clinical analysis of primary T-cell lymphoma of the gastrointestinal tract according to pathological subtype
124. Risk factors and clinical outcomes of gastric cancer identified by screening endoscopy: A case–control study
125. Degree of Healing and Healing-Associated Factors of Endoscopic Submucosal Dissection-Induced Ulcers After Pantoprazole Therapy for 4 Weeks
126. Application of metal hemoclips for closure of endoscopic mucosal resection–induced ulcers of the stomach to prevent delayed bleeding
127. Associations of Serum Lipid Level with Gastric Cancer Risk, Pathology, and Prognosis
128. Prevalence and endoscopic treatment outcomes of upper gastrointestinal neoplasms in familial adenomatous polyposis
129. Additional file 1 of Effect of Helicobacter pylori eradication on reflux esophagitis and GERD symptoms after endoscopic resection of gastric neoplasm: a single-center prospective study
130. RISK FACTORS ASSOCIATED WITH LOCAL RECURRENCE OF GASTRIC HYPERPLASTIC POLYP: A SINGLE-CENTER, LONG-TERM RETROSPECTIVE COHORT STUDY
131. Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for Helicobacter pylori Eradication in the Clinical Setting
132. Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma
133. Predictive Role of Endoscopic Surveillance after Total Gastrectomy with R0 Resection for Gastric Cancer
134. Close Observation versus Additional Surgery after Noncurative Endoscopic Resection of Esophageal Squamous Cell Carcinoma
135. Seroconversion Rates of Helicobacter pylori Infection in Korean Adults
136. Optimal Biopsy Site for Helicobacter pylori Detection during Endoscopic Mucosectomy in Patients with Extensive Gastric Atrophy
137. Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance
138. Second-line Helicobacter pylori Eradication: A Randomized Comparison of 1-week or 2-week Bismuth-containing Quadruple Therapy
139. Extended indication of endoscopic resection for mucosal early gastric cancer: Analysis of a single center experience
140. The Role of Abdominal CT Scan as Follow-up after Complete Remission with Successful Helicobacter pylori Eradication in Patients with H. pylori-Positive Stage IE1 Gastric MALT Lymphoma
141. Clinical Outcomes of Percutaneous Endoscopic Gastrostomy in the Surgical Intensive Care Unit
142. Modified bismuth quadruple therapy with low‐dose metronidazole as first‐line therapy for Helicobacter pylori infection
143. Endoscopic submucosal dissection as alternative to surgery for complicated gastric heterotopic pancreas
144. Comparison of the Efficacy and Safety of Endoscopic Incisional Therapy and Balloon Dilatation for Esophageal Anastomotic Stricture
145. Clinical course of duodenal mucosa‐associated lymphoid tissue lymphoma: Comparison with gastric mucosa‐associated lymphoid tissue lymphoma
146. Genotypic and Phenotypic Resistance to Clarithromycin in Helicobacter pylori Strains
147. Mo1276 COMPARISON OF THE EFFICACY AND SAFETY OF ENDOSCOPIC INCISIONAL THERAPY AND BALLOON DILATATION FOR ESOPHAGEAL ANASTOMOTIC STRICTURE
148. Su1037 DEVELOPEMENT OF ENDOSCOPIC SCORING SYSTEM TO PREDICT RISK OF INTESTINAL TYPE OF GASTRIC CANCER
149. Preliminary results of a phase II study of neoadjuvant immune checkpoint inhibitor IMC-001 (anti-PD-L1 monoclonal antibody) in patients with resectable gastrointestinal cancers (NeoChance Study).
150. New parameter for quantifying bolus transit with high‐resolution impedance manometry: A comparison with simultaneous esophagogram
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.